Monday, July 15, 2024

Canada Takes Bold Steps to Improve Drug Access and Sustainability

Similar articles

The Government of Canada is taking significant steps to enhance the country’s pharmaceutical system and ensure Canadians have better drug access. High drug costs, inaccessible health data, and inconsistent prescribing practices have left many Canadians vulnerable. In response, the Canadian Drug Agency Transition Office (CDATO) conducted extensive consultations with provinces, territories (PTs), and key stakeholders to identify critical gaps in the pharmaceutical system.

Mark Holland, Minister of Health, announced the creation of the Canadian Drug Agency (CDA), marking a significant milestone in strengthening Canada’s pharmaceutical system. The CDA will play a crucial role in making the system more sustainable and better prepared for the future, ultimately improving the health outcomes of Canadians.

Canada Invests Heavily in New Canadian Drug Agency to Improve Drug Access and Pharmaceutical Systems

The CDA will be established in collaboration with provinces and territories and will build upon the existing Canadian Agency for Drugs and Technologies in Health (CADTH). The Government of Canada is investing $89.5 million over five years to set up the CDA, in addition to the existing annual federal funding of $34.2 million to support CADTH.

The CDA will expand on CADTH’s pharmaceutical expertise, including health technology assessment and post-market safety and effectiveness evaluations. It will also introduce new initiatives, such as improving medication prescribing practices, expanding data collection, and reducing inefficiencies in the drug system.

Drug Access

Canada’s Vision for a Stronger Drug System with the Canadian Drug Agency

The Government will work closely with CADTH and provinces and territories to develop the CDA. Once operational, the CDA will take on a more substantial role in the drug system, ensuring Canadians have the drug access they need while enhancing their overall health outcomes.

Minister Holland emphasized, “The establishment of the Canadian Drug Agency is an important step in supporting the long-term sustainability of Canada’s drug system, improving data quality, and ultimately helping Canadians improve their quality of life and overall health.”

This announcement builds on the Government’s commitment to improving drug access and affordability, reinforcing Canada’s pharmaceutical landscape for the benefit of all Canadians.


You can follow our news on our Telegram and LinkedIn accounts.

Resource: Canada’s Drug and Health Technology Agency, December 18, 2023

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article